4//SEC Filing
BOUDREAUX GAIL 4
Accession 0001287920-25-000005
CIK 0001156039other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 1:42 PM ET
Size
9.5 KB
Accession
0001287920-25-000005
Insider Transaction Report
Form 4
BOUDREAUX GAIL
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-07-18$287.12/sh+5,116$1,468,906→ 149,970 total - Purchase
Common Stock
2025-07-18$287.96/sh+1,050$302,358→ 151,020 total - Purchase
Common Stock
2025-07-18$286.07/sh+2,334$667,687→ 144,854 total
Holdings
- 60(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This transaction was executed in multiple purchases at prices ranging from $285.50 to $286.43. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple purchases at prices ranging from $286.70 to $287.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple purchases at prices ranging from $287.72 to $288.14. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Elevance Health, Inc.
CIK 0001156039
Entity typeother
Related Parties
1- filerCIK 0001287920
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 1:42 PM ET
- Size
- 9.5 KB